Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease

被引:11
作者
Wu, Weiti [1 ]
Xiang, Jingjing [2 ]
Chen, Xiaoye [3 ]
机构
[1] Taizhou Hosp, Dept Infect Dis, Taizhou, Zhejiang, Peoples R China
[2] Taizhou Hosp, Dept Emergency, Taizhou, Zhejiang, Peoples R China
[3] Taizhou Hosp, Dept Radiotherapy, Taizhou, Zhejiang, Peoples R China
关键词
non-alcoholic fatty liver disease; diabetes mellitus; NHANES; cardiovascular; mortality; HEPATIC INSULIN-RESISTANCE; NAFLD; RISK; PATHOGENESIS; MEN;
D O I
10.3389/fendo.2021.773342
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThe influence of diabetes on mortality among patients with non-alcoholic fatty liver disease (NAFLD) in the general population has not been extensively studied. This study aimed to determine the relationship between diabetes and all-cause and cardiovascular mortality in patients with hepatic ultrasound-confirmed NAFLD using data from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. MethodsData from 4,037 adult individuals with NAFLD from the NHANES III and mortality outcomes linked to National Death Index records through December 31, 2015, were included. Cox proportional hazards models were used to calculate the hazard ratio (HR) and corresponding 95% CI for mortality from all causes and cardiovascular disease after adjusting for multiple variables. ResultsAmong 4,037 subjects with NAFLD (55.9% female), 483 had diabetes at baseline. During a median follow-up of 22.1 years, 1,517 (11.5%) died, including 332 (8.22%) from cardiovascular causes. Diabetes was associated with increased all-cause (HR 3.02 [95% CI 2.67-3.41]) and cardiovascular (HR 3.36 [95% CI 2.61-4.32]) mortality in an unadjusted multivariable Cox regression model. The association remained statistically significant after adjusting for a range of potential confounders (HR 2.20 [95% CI 1.90-2.55] for all-cause mortality and HR 2.47 [95% CI 1.81-3.37] for cardiovascular mortality). An additional stratified analysis did not reveal significantly altered results. ConclusionDiabetes was associated with all-cause and cardiovascular mortality in patients with NAFLD. This link could be further characterized in future studies assessing the degree of glycemic control and its relationship with mortality in patients with diabetes and NAFLD.
引用
收藏
页数:9
相关论文
共 39 条
[1]   Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study [J].
Adams, Leon A. ;
Harmsen, Scott ;
St Sauver, Jennifer L. ;
Charatcharoenwitthaya, Phunchai ;
Enders, Felicity B. ;
Therneau, Terry ;
Angulo, Paul .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (07) :1567-1573
[2]   Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis [J].
Anstee, Quentin M. ;
Targher, Giovanni ;
Day, Christopher P. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (06) :330-344
[3]   Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance [J].
Asrih, Mohamed ;
Jornayvaz, Francois R. .
JOURNAL OF ENDOCRINOLOGY, 2013, 218 (03) :R25-R36
[4]   Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis [J].
Ballestri, Stefano ;
Zona, Stefano ;
Targher, Giovanni ;
Romagnoli, Dante ;
Baldelli, Enrica ;
Nascimbeni, Fabio ;
Roverato, Alberto ;
Guaraldi, Giovanni ;
Lonardo, Amedeo .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) :936-944
[5]   Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting [J].
Barbosa, Joana Vieira ;
Lai, Michelle .
HEPATOLOGY COMMUNICATIONS, 2021, 5 (02) :158-167
[6]   Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes [J].
Bergman, Richard N. ;
Piccinini, Francesca ;
Kabir, Morvarid ;
Kolka, Cathryn M. ;
Ader, Marilyn .
DIABETES, 2019, 68 (09) :1709-1716
[7]   Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes [J].
Birkenfeld, Andreas L. ;
Shulman, Gerald I. .
HEPATOLOGY, 2014, 59 (02) :713-723
[8]   NAFLD: A multisystem disease [J].
Byrne, Christopher D. ;
Targher, Giovanni .
JOURNAL OF HEPATOLOGY, 2015, 62 :S47-S64
[9]   Increased Risk of Type 2 Diabetes in Subjects with Both Elevated Liver Enzymes and Ultrasonographically Diagnosed Nonalcoholic Fatty Liver Disease: A 4-year Longitudinal Study [J].
Choi, Ji Hun ;
Rhee, Eun Jung ;
Bae, Ji Cheol ;
Park, Se Eun ;
Park, Cheol Young ;
Cho, Yong Kyun ;
Oh, Ki Won ;
Park, Sung Woo ;
Lee, Won Young .
ARCHIVES OF MEDICAL RESEARCH, 2013, 44 (02) :115-120
[10]   Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study [J].
Dasarathy, Srinivasan ;
Dasarathy, Jaividhya ;
Khiyami, Amer ;
Joseph, Rajesh ;
Lopez, Rocio ;
McCullough, Arthur J. .
JOURNAL OF HEPATOLOGY, 2009, 51 (06) :1061-1067